Emerging roles of endoplasmic reticulum-resident selenoproteins in the regulation of cellular stress responses and the implications for metabolic disease

Biochemical Journal

Volumn 475, Issue 6, 2018, Pages 1037-1057

  Addinsall, Alex B ^a   Wright, Craig R ^b   Andrikopoulos, Sof ^c   van der Poel, Chris ^d   Stupka, Nicole ^a  

^a DEAKIN UNIVERSITY   (Australia)

^b DEAKIN UNIVERSITY   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d LA TROBE UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; OXIDOREDUCTASE; SELENOPROTEIN; SELENOPROTEIN K; SELENOPROTEIN M; SELENOPROTEIN N; SELENOPROTEIN S; SELENOPROTEIN T; TYPE 2 IODOTHYRONINE DEIODINASE; UNCLASSIFIED DRUG; REACTIVE OXYGEN METABOLITE;

CALCIUM HOMEOSTASIS; CARDIOVASCULAR DISEASE; CELLULAR STRESS RESPONSE; CHRONIC DISEASE; DIETARY INTAKE; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM STRESS; HUMAN; INFLAMMATION; METABOLIC DISORDER; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SKELETAL MUSCLE; TRANSCRIPTION REGULATION; ANIMAL; GENETICS; METABOLISM; MOUSE; PHYSIOLOGY;

ANIMALS; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM STRESS; HUMANS; METABOLIC DISEASES; MICE; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SELENOPROTEINS;

EID: 85046887684     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BCJ20170920     Document Type: Review

References (208)

1. Shaw, K., Gennat, H., O’Rourke, P. and Del Mar, C. (2006) Exercise for overweight or obesity. Cochrane Database Syst. Rev. CD003817 PMID:17054187
2. Basson, M. (2008) Cardiovascular disease. Nature 451, 903 https://doi.org/10.1038/451903a
3. Olokoba, A.B., Obateru, O.A. and Olokoba, L.B. (2012) Type 2 diabetes mellitus: a review of current trends. Oman Med. J. 27, 269–273 https://doi.org/10.5001/omj.2012.68
4. Carnethon, M.R., Loria, C.M., Hill, J.O., Sidney, S., Savage, P.J. and Liu, K. (2004) Risk factors for the metabolic syndrome: the Coronary Artery Risk Development in Young Adults (CARDIA) study, 1985–2001. Diabetes Care 27, 2707–2715 https://doi.org/10.2337/diacare.27.11.2707
5. Chaudhari, N., Talwar, P., Parimisetty, A., Lefebvre d’Hellencourt, C. and Ravanan, P. (2014) A molecular web: endoplasmic reticulum stress, inflammation, and oxidative stress. Front. Cell. Neurosci. 8, 213 https://doi.org/10.3389/fncel.2014.00213
6. Savini, I., Catani, M.V., Evangelista, D., Gasperi, V. and Avigliano, L. (2013) Obesity-associated oxidative stress: strategies finalized to improve redox state. Int. J. Mol. Sci. 14, 10497–10538 https://doi.org/10.3390/ijms140510497
7. Patti, M.E. and Corvera, S. (2010) The role of mitochondria in the pathogenesis of type 2 diabetes. Endocr. Rev. 31, 364–395 https://doi.org/10.1210/er.2009-0027
8. Hotamisligil, G.S. (2010) Endoplasmic reticulum stress and atherosclerosis. Nat. Med. 16, 396–399 https://doi.org/10.1038/nm0410-396
9. Zhang, K. (2010) Integration of ER stress, oxidative stress and the inflammatory response in health and disease. Int. J. Clin. Exp. Med. 3, 33–40 PMID:20369038
10. Kim, I., Xu, W. and Reed, J.C. (2008) Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities. Nat. Rev. Drug Discov. 7, 1013–1030 https://doi.org/10.1038/nrd2755
11. Fagone, P. and Jackowski, S. (2009) Membrane phospholipid synthesis and endoplasmic reticulum function. J. Lipid Res. 50, S311–S316 https://doi.org/10.1194/jlr.R800049-JLR200
12. Sanders, L.H., Mabadeje, S.A., Avis, K.E., Cruze, III, C.A., and Martinez, D.R. (1978) Evaluation of compounding accuracy and aseptic techniques for intravenous admixtures. Am. J. Hosp. Pharm. 35, 531–536 PMID:350042
13. Sevier, C.S. and Kaiser, C.A. (2008) Ero1 and redox homeostasis in the endoplasmic reticulum. Biochim. Biophys. Acta 1783, 549–556 https://doi.org/10.1016/j.bbamcr.2007.12.011
14. Ramming, T., Okumura, M., Kanemura, S., Baday, S., Birk, J., Moes, S. et al. (2015) A PDI-catalyzed thiol-disulfide switch regulates the production of hydrogen peroxide by human Ero1. Free Radic. Biol. Med. 83, 361–372 https://doi.org/10.1016/j.freeradbiomed.2015.02.011
15. Benham, A.M., van Lith, M., Sitia, R. and Braakman, I. (2013) Ero1–PDI interactions, the response to redox flux and the implications for disulfide bond formation in the mammalian endoplasmic reticulum. Philos. Trans. R. Soc. B Biol. Sci. 368, 20110403 https://doi.org/10.1098/rstb.2011.0403
16. Hwang, C., Sinskey, A.J. and Lodish, H.F. (1992) Oxidized redox state of glutathione in the endoplasmic reticulum. Science 257, 1496–1502 https://doi.org/10.1126/science.1523409
17. Bhandary, B., Marahatta, A., Kim, H.-R. and Chae, H.-J. (2013) An involvement of oxidative stress in endoplasmic reticulum stress and its associated diseases. Int. J. Mol. Sci. 14, 434–456 https://doi.org/10.3390/ijms14010434
18. Shchedrina, V.A., Zhang, Y., Labunskyy, V.M., Hatfield, D.L. and Gladyshev, V.N. (2010) Structure-function relations, physiological roles, and evolution of mammalian ER-resident selenoproteins. Antioxid. Redox Signal. 12, 839–849 https://doi.org/10.1089/ars.2009.2865
19. Feske, S. (2007) Calcium signalling in lymphocyte activation and disease. Nat. Rev. Immunol. 7, 690–702 https://doi.org/10.1038/nri2152
20. Jouaville, L.S., Pinton, P., Bastianutto, C., Rutter, G.A. and Rizzuto, R. (1999) Regulation of mitochondrial ATP synthesis by calcium: evidence for a long-term metabolic priming. Proc. Natl Acad. Sci. U.S.A. 96, 13807–13812 https://doi.org/10.1073/pnas.96.24.13807
21. Bergsten, P. (2002) Chapter 8 calcium dysregulation, insulin release and the pathogenesis of diabetes. Adv. Cell Aging Gerontol. 10, 147–166 https://doi.org/10.1016/S1566-3124(02)10020-4
22. Lamb, G.D. and Westerblad, H. (2011) Acute effects of reactive oxygen and nitrogen species on the contractile function of skeletal muscle. J. Physiol. 589, 2119–2127 https://doi.org/10.1113/jphysiol.2010.199059
23. Posterino, G.S., Cellini, M.A. and Lamb, G.D. (2003) Effects of oxidation and cytosolic redox conditions on excitation-contraction coupling in rat skeletal muscle. J. Physiol. 547, 807–823 https://doi.org/10.1113/jphysiol.2002.035204
24. 3) receptors by reactive oxygen species. J. Biol. Chem. 289, 8170–8181 https://doi.org/10.1074/jbc.M113.504159
25. Andrade, F.H., Reid, M.B., Allen, D.G. and Westerblad, H. (1998) Effect of hydrogen peroxide and dithiothreitol on contractile function of single skeletal muscle fibres from the mouse. J. Physiol. 509 (Pt 2), 565–575 https://doi.org/10.1111/j.1469-7793.1998.565bn.x
26. Andrade, F.H., Reid, M.B. and Westerblad, H. (2001) Contractile response of skeletal muscle to low peroxide concentrations: myofibrillar calcium sensitivity as a likely target for redox-modulation. FASEB J. 15, 309–311 https://doi.org/10.1096/fj.00-0507fje
27. 2+ depletion in cardiac myocytes. Free Radic. Biol. Med. 48, 1182–1187 https://doi.org/10.1016/j.freeradbiomed.2010.01.038
28. Balderas-Villalobos, J., Molina-Munoz, T., Mailloux-Salinas, P., Bravo, G., Carvajal, K. and Gomez-Viquez, N.L. (2013) Oxidative stress in cardiomyocytes contributes to decreased SERCA2a activity in rats with metabolic syndrome. Am. J. Physiol. Heart Circ. Physiol. 305, H1344–H1353 https://doi.org/10.1152/ajpheart.00211.2013
29. Brown, K.M. and Arthur, J.R. (2001) Selenium, selenoproteins and human health: a review. Public Health Nutr. 4, 593–599 https://doi.org/10.1079/ PHN2001143
30. Forman, H.J., Rotman, E.I. and Fisher, A.B. (1983) Roles of selenium and sulfur-containing amino acids in protection against oxygen toxicity. Lab. Invest. 49, 148–153 PMID:6876743
31. Li, F., Lutz, P.B., Pepelyayeva, Y., Arner, E.S., Bayse, C.A. and Rozovsky, S. (2014) Redox active motifs in selenoproteins. Proc. Natl Acad. Sci. U.S.A. 111, 6976–6981 https://doi.org/10.1073/pnas.1319022111
32. Johansson, L., Gafvelin, G. and Arnér, E.S. (2005) Selenocysteine in proteins — properties and biotechnological use. Biochim. Biophys. Acta 1726, 1–13 https://doi.org/10.1016/j.bbagen.2005.05.010
33. Pinto, A., Juniper, D.T., Sanil, M., Morgan, L., Clark, L., Sies, H. et al. (2012) Supranutritional selenium induces alterations in molecular targets related to energy metabolism in skeletal muscle and visceral adipose tissue of pigs. J. Inorg. Biochem. 114, 47–54 https://doi.org/10.1016/j.jinorgbio.2012.04.011
34. Huang, Z., Rose, A.H. and Hoffmann, P.R. (2012) The role of selenium in inflammation and immunity: from molecular mechanisms to therapeutic opportunities. Antioxid. Redox Signal. 16, 705–743 https://doi.org/10.1089/ars.2011.4145
35. Nazemi, L., Shariat, M., Chamari, M., Chahardoli, R., Asgarzadeh, L. and Seighali, F. (2015) Comparison of maternal and umbilical cord blood selenium levels in low and normal birth weight neonates. J. Family Reprod. Health 9, 125–128 PMID:26622311
36. Oropeza-Moe, M., Wisløff, H. and Bernhoft, A. (2015) Selenium deficiency associated porcine and human cardiomyopathies. J. Trace Elem. Med. Biol. 31, 148–156 https://doi.org/10.1016/j.jtemb.2014.09.011
37. Ferreiro, A., Quijano-Roy, S., Pichereau, C., Moghadaszadeh, B., Goemans, N., Bönnemann, C. et al. (2002) Mutations of the selenoprotein N gene, which is implicated in rigid spine muscular dystrophy, cause the classical phenotype of multiminicore disease: reassessing the nosology of early-onset myopathies. Am. J. Hum. Genet. 71, 739–749 https://doi.org/10.1086/342719
38. Clarke, N.F., Kidson, W., Quijano-Roy, S., Estournet, B., Ferreiro, A., Guicheney, P. et al. (2006) SEPN1: associated with congenital fiber-type disproportion and insulin resistance. Ann. Neurol. 59, 546–552 https://doi.org/10.1002/ana.20761
39. Maiti, B., Arbogast, S., Allamand, V., Moyle, M.W., Anderson, C.B., Richard, P. et al. (2009) A mutation in the SEPN1 selenocysteine redefinition element (SRE) reduces selenocysteine incorporation and leads to SEPN1-related myopathy. Hum. Mutat. 30, 411–416 https://doi.org/10.1002/humu.20879
40. Moghadaszadeh, B., Petit, N., Jaillard, C., Brockington, M., Quijano Roy, S., Merlini, L. et al. (2001) Mutations in SEPN1 cause congenital muscular dystrophy with spinal rigidity and restrictive respiratory syndrome. Nat. Genet. 29, 17–18 https://doi.org/10.1038/ng713
41. Ferreiro, A., Ceuterick-de Groote, C., Marks, J.J., Goemans, N., Schreiber, G., Hanefeld, F. et al. (2004) Desmin-related myopathy with Mallory body-like inclusions is caused by mutations of the selenoprotein N gene. Ann. Neurol. 55, 676–686 https://doi.org/10.1002/ana.20077
42. Farrokhian, A., Bahmani, F., Taghizadeh, M., Mirhashemi, S.M., Aarabi, M.H., Raygan, F. et al. (2016) Selenium supplementation affects insulin resistance and serum hs-CRP in patients with type 2 diabetes and coronary heart disease. Horm. Metab. Res. 48, 263–268 https://doi.org/10.1055/s-0035-1569276
43. Rayman, M.P. (2000) The importance of selenium to human health. Lancet 356, 233–241 https://doi.org/10.1016/S0140-6736(00)02490-9
44. Duffield, A.J., Thomson, C.D., Hill, K.E. and Williams, S. (1999) An estimation of selenium requirements for New Zealanders. Am. J. Clin. Nutr. 70, 896–903 https://doi.org/10.1093/ajcn/70.5.896
45. Xia, Y., Hill, K.E., Byrne, D.W., Xu, J. and Burk, R.F. (2005) Effectiveness of selenium supplements in a low-selenium area of China. Am. J. Clin. Nutr. 81, 829–834 https://doi.org/10.1093/ajcn/81.4.829
46. Pasco, J.A., Jacka, F.N., Williams, L.J., Evans-Cleverdon, M., Brennan, S.L., Kotowicz, M.A. et al. (2012) Dietary selenium and major depression: a nested case-control study. Complement. Ther. Med. 20, 119–123 https://doi.org/10.1016/j.ctim.2011.12.008
47. Jain, R.B. and Choi, Y.S. (2015) Normal reference ranges for and variability in the levels of blood manganese and selenium by gender, age, and race/ ethnicity for general U.S. population. J. Trace Elem. Med. Biol. 30, 142–152 https://doi.org/10.1016/j.jtemb.2014.12.004
48. Ge, K. and Yang, G. (1993) The epidemiology of selenium deficiency in the etiological study of endemic diseases in China. Am. J. Clin. Nutr. 57, 259s–263s https://doi.org/10.1093/ajcn/57.2.259S
49. Stoffaneller, R. and Morse, N.L. (2015) A review of dietary selenium intake and selenium status in Europe and the Middle East. Nutrients 7, 1494–1537 https://doi.org/10.3390/nu7031494
50. Li, S., Yang, L., Wang, W., Li, Y., Li, H. and Xirao, R. (2007) Relationship between selenium concentration in child hair and the distribution of Kashin-Beck disease in Tibet, China. Front. Med. China. 1, 223–225 https://doi.org/10.1007/s11684-007-0043-1
51. Combs, Jr, G.F., Clark, L.C. and Turnbull, B.W. (2001) An analysis of cancer prevention by selenium. Biofactors 14, 153–159 https://doi.org/10.1002/biof.5520140120
52. Hornberger, T.A., McLoughlin, T.J., Leszczynski, J.K., Armstrong, D.D., Jameson, R.R., Bowen, P.E. et al. (2003) Selenoprotein-deficient transgenic mice exhibit enhanced exercise-induced muscle growth. J. Nutr. 133, 3091–3097 https://doi.org/10.1093/jn/133.10.3091
53. Brinkman, M., Reulen, R.C., Kellen, E., Buntinx, F. and Zeegers, M.P. (2006) Are men with low selenium levels at increased risk of prostate cancer? Eur. J. Cancer 42, 2463–2471 https://doi.org/10.1016/j.ejca.2006.02.027
54. Zou, K., Liu, G., Wu, T. and Du, L. (2009) Selenium for preventing Kashin-Beck osteoarthropathy in children: a meta-analysis. Osteoarthritis Cartilage 17, 144–151 https://doi.org/10.1016/j.joca.2008.06.011
55. Muller, A.S., Most, E. and Pallauf, J. (2005) Effects of a supranutritional dose of selenate compared with selenite on insulin sensitivity in type II diabetic dbdb mice. J. Anim. Physiol. Anim. Nutr. 89, 94–104 https://doi.org/10.1111/j.1439-0396.2005.00559.x
56. Akbaraly, T.N., Arnaud, J., Rayman, M.P., Hininger-Favier, I., Roussel, A.M., Berr, C. et al. (2010) Plasma selenium and risk of dysglycemia in an elderly French population: results from the prospective Epidemiology of Vascular Ageing Study. Nutr. Metab. 7, 21 https://doi.org/10.1186/ 1743-7075-7-21
57. Kljai, K. and Runje, R. (2001) Selenium and glycogen levels in diabetic patients. Biol. Trace Elem. Res. 83, 223–229 https://doi.org/10.1385/BTER:83:3:223
58. Rajpathak, S., Rimm, E., Morris, J.S. and Hu, F. (2005) Toenail selenium and cardiovascular disease in men with diabetes. J. Am. Coll. Nutr. 24, 250–256 https://doi.org/10.1080/07315724.2005.10719472
59. Flores-Mateo, G., Navas-Acien, A., Pastor-Barriuso, R. and Guallar, E. (2006) Selenium and coronary heart disease: a meta-analysis. Am. J. Clin. Nutr. 84, 762–773 https://doi.org/10.1093/ajcn/84.4.762
60. Lubos, E., Sinning, C.R., Schnabel, R.B., Wild, P.S., Zeller, T., Rupprecht, H.J. et al. (2010) Serum selenium and prognosis in cardiovascular disease: results from the AtheroGene study. Atherosclerosis 209, 271–277 https://doi.org/10.1016/j.atherosclerosis.2009.09.008
61. Stranges, S., Marshall, J.R., Trevisan, M., Natarajan, R., Donahue, R.P., Combs, G.F. et al. (2006) Effects of selenium supplementation on cardiovascular disease incidence and mortality: secondary analyses in a randomized clinical trial. Am. J. Epidemiol. 163, 694–699 https://doi.org/10.1093/aje/kwj097
62. Hawkes, W.C., Alkan, Z. and Wong, K. (2009) Selenium supplementation does not affect testicular selenium status or semen quality in North American men. J. Androl. 30, 525–533 https://doi.org/10.2164/jandrol.108.006940
63. Schnabel, R., Lubos, E., Messow, C.M., Sinning, C.R., Zeller, T., Wild, P.S. et al. (2008) Selenium supplementation improves antioxidant capacity in vitro and in vivo in patients with coronary artery disease: the SElenium Therapy in Coronary Artery disease Patients (SETCAP) study. Am. Heart J. 156, 1201. e1–1201.e11 https://doi.org/10.1016/j.ahj.2008.09.004
64. Lippman, S.M., Klein, E.A., Goodman, P.J., Lucia, M.S., Thompson, I.M., Ford, L.G., et al. (2009) Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 301, 39–51 https://doi.org/10.1001/jama.2008.864
65. Stranges, S., Marshall, J.R., Natarajan, R., Donahue, R.P., Trevisan, M., Combs, G.F. et al. (2007) Effects of long-term selenium supplementation on the incidence of type 2 diabetes: a randomized trial. Ann. Intern. Med. 147, 217–223 https://doi.org/10.7326/0003-4819-147-4-200708210-00175
66. Wang, Y., Lin, M., Gao, X., Pedram, P., Du, J., Vikram, C. et al. (2017) High dietary selenium intake is associated with less insulin resistance in the Newfoundland population. PLoS ONE 12, e0174149 https://doi.org/10.1371/journal.pone.0174149
67. Lu, C.W., Chang, H.H., Yang, K.C., Kuo, C.S., Lee, L.T. and Huang, K.C. (2016) High serum selenium levels are associated with increased risk for diabetes mellitus independent of central obesity and insulin resistance. BMJ Open Diabetes Res. Care 4, e000253 https://doi.org/10.1136/ bmjdrc-2016-000253
68. Labunskyy, V.M., Lee, B.C., Handy, D.E., Loscalzo, J., Hatfield, D.L. and Gladyshev, V.N. (2011) Both maximal expression of selenoproteins and selenoprotein deficiency can promote development of type 2 diabetes-like phenotype in mice. Antioxid. Redox Signal. 14, 2327–2336 https://doi.org/10.1089/ars.2010.3526
69. Wang, X., Zhang, W., Chen, H., Liao, N., Wang, Z., Zhang, X. et al. (2014) High selenium impairs hepatic insulin sensitivity through opposite regulation of ROS. Toxicol. Lett. 224, 16–23 https://doi.org/10.1016/j.toxlet.2013.10.005
70. Laclaustra, M., Navas-Acien, A., Stranges, S., Ordovas, J.M. and Guallar, E. (2009) Serum selenium concentrations and diabetes in U.S. adults: National Health and Nutrition Examination Survey (NHANES) 2003-2004. Environ. Health Perspect. 117, 1409–1413 https://doi.org/10.1289/ehp. 0900704
71. Morris, J.S. and Crane, S.B. (2013) Selenium toxicity from a misformulated dietary supplement, adverse health effects, and the temporal response in the nail biologic monitor. Nutrients 5, 1024–1057 https://doi.org/10.3390/nu5041024
72. MacFarquhar, J.K., Broussard, D.L., Melstrom, P., Hutchinson, R., Wolkin, A., Martin, C. et al. (2010) Acute selenium toxicity associated with a dietary supplement. Arch. Intern. Med. 170, 256–261 https://doi.org/10.1001/archinternmed.2009.495
73. Hatfield, D.L. and Gladyshev, V.N. (2002) How selenium has altered our understanding of the genetic code. Mol. Cell. Biol. 22, 3565–3576 https://doi.org/10.1128/MCB.22.11.3565-3576.2002
74. Bulteau, A.L. and Chavatte, L. (2015) Update on selenoprotein biosynthesis. Antioxid. Redox Signal. 23, 775–794 https://doi.org/10.1089/ars.2015.6391
75. Tsuji, P.A., Carlson, B.A., Anderson, C.B., Seifried, H.E., Hatfield, D.L. and Howard, M.T. (2015) Dietary selenium levels affect selenoprotein expression and support the interferon-γ and IL-6 immune response pathways in mice. Nutrients 7, 6529–6549 https://doi.org/10.3390/nu7085297
76. Kipp, A., Banning, A., van Schothorst, E.M., Meplan, C., Schomburg, L., Evelo, C. et al. (2009) Four selenoproteins, protein biosynthesis, and Wnt signalling are particularly sensitive to limited selenium intake in mouse colon. Mol. Nutr. Food Res. 53, 1561–1572 https://doi.org/10.1002/mnfr.200900105
77. Touat-Hamici, Z., Legrain, Y., Bulteau, A.L. and Chavatte, L. (2014) Selective up-regulation of human selenoproteins in response to oxidative stress. J. Biol. Chem. 289, 14750–14761 https://doi.org/10.1074/jbc.M114.551994
78. Curran, J.E., Jowett, J.B., Elliott, K.S., Gao, Y., Gluschenko, K., Wang, J. et al. (2005) Genetic variation in selenoprotein S influences inflammatory response. Nat. Genet. 37, 1234–1241 https://doi.org/10.1038/ng1655
79. Ben, S.B., Peng, B., Wang, G.C., Li, C., Gu, H.F., Jiang, H. et al. (2015) Overexpression of selenoprotein SelK in BGC-823 cells inhibits cell adhesion and migration. Biochemistry 80, 1344–1353 https://doi.org/10.1134/S0006297915100168
80. Verma, S., Hoffmann, F.W., Kumar, M., Huang, Z., Roe, K., Nguyen-Wu, E. et al. (2011) Selenoprotein K knockout mice exhibit deficient calcium flux in immune cells and impaired immune responses. J. Immunol. 186, 2127–2137 https://doi.org/10.4049/jimmunol.1002878
81. Korotkov, K.V., Kumaraswamy, E., Zhou, Y., Hatfield, D.L. and Gladyshev, V.N. (2001) Association between the 15-kDa selenoprotein and UDP-glucose:glycoprotein glucosyltransferase in the endoplasmic reticulum of mammalian cells. J. Biol. Chem. 276, 15330–15336 https://doi.org/10.1074/jbc.M009861200
82. Labunskyy, V.M., Ferguson, A.D., Fomenko, D.E., Chelliah, Y., Hatfield, D.L. and Gladyshev, V.N. (2005) A novel cysteine-rich domain of Sep15 mediates the interaction with UDP-glucose:glycoprotein glucosyltransferase. J. Biol. Chem. 280, 37839–37845 https://doi.org/10.1074/jbc.M508685200
83. Kasaikina, M.V., Fomenko, D.E., Labunskyy, V.M., Lachke, S.A., Qiu, W., Moncaster, J.A. et al. (2011) Roles of the 15-kDa selenoprotein (Sep15) in redox homeostasis and cataract development revealed by the analysis of Sep 15 knockout mice. J. Biol. Chem. 286, 33203–33212 https://doi.org/10.1074/jbc.M111.259218
84. Prevost, G., Arabo, A., Jian, L., Quelennec, E., Cartier, D., Hassan, S. et al. (2013) The PACAP-regulated gene selenoprotein T is abundantly expressed in mouse and human β-cells and its targeted inactivation impairs glucose tolerance. Endocrinology 154, 3796–3806 https://doi.org/10.1210/en. 2013-1167
85. Pitts, M.W., Reeves, M.A., Hashimoto, A.C., Ogawa, A., Kremer, P., Seale, L.A. et al. (2013) Deletion of selenoprotein M leads to obesity without cognitive deficits. J. Biol. Chem. 288, 26121–26134 https://doi.org/10.1074/jbc.M113.471235
86. Ozcan, L., Ergin, A.S., Lu, A., Chung, J., Sarkar, S., Nie, D. et al. (2009) Endoplasmic reticulum stress plays a central role in development of leptin resistance. Cell Metab. 9, 35–51 https://doi.org/10.1016/j.cmet.2008.12.004
87. Meiler, S., Baumer, Y., Huang, Z., Hoffmann, F.W., Fredericks, G.J., Rose, A.H. et al. (2013) Selenoprotein K is required for palmitoylation of CD36 in macrophages: implications in foam cell formation and atherogenesis. J. Leukoc. Biol. 93, 771–780 https://doi.org/10.1189/jlb.1212647
88. Hwang, D.Y., Cho, J.S., Oh, J.H., Shim, S.B., Jee, S.W., Lee, S.H. et al. (2005) Differentially expressed genes in transgenic mice carrying human mutant presenilin-2 (N141I): correlation of selenoprotein M with Alzheimer’s disease. Neurochem. Res. 30, 1009–1019 https://doi.org/10.1007/ s11064-005-6787-6
89. Coller, H.A. (2014) Is cancer a metabolic disease? Am. J. Pathol. 184, 4–17 https://doi.org/10.1016/j.ajpath.2013.07.035
90. Davis, C.D., Tsuji, P.A. and Milner, J.A. (2012) Selenoproteins and cancer prevention. Annu. Rev. Nutr. 32, 73–95 https://doi.org/10.1146/ annurev-nutr-071811-150740
91. Almondes, K.G.d.S., Leal, G.V.d.S., Cozzolino, S.M.F., Philippi, S.T. and Rondó, P.H.d.C. (2010) O papel das selenoproteínas no câncer. Rev. Assoc. Med. Bras. 56, 484–488 https://doi.org/10.1590/S0104-42302010000400025
92. Evans, S.O., Khairuddin, P.F. and Jameson, M.B. (2017) Optimising selenium for modulation of cancer treatments. Anticancer Res. 37, 6497–6509 https://doi.org/10.21873/anticanres.12106
93. Shibata, T., Arisawa, T., Tahara, T., Ohkubo, M., Yoshioka, D., Maruyama, N. et al. (2009) Selenoprotein S (SEPS1) gene -105G>A promoter polymorphism influences the susceptibility to gastric cancer in the Japanese population. BMC Gastroenterol. 9, 2 https://doi.org/10.1186/ 1471-230X-9-2
94. Sutherland, A., Kim, D.H., Relton, C., Ahn, Y.O. and Hesketh, J. (2010) Polymorphisms in the selenoprotein S and 15-kDa selenoprotein genes are associated with altered susceptibility to colorectal cancer. Genes Nutr. 5, 215–223 https://doi.org/10.1007/s12263-010-0176-8
95. Hart, K., Landvik, N.E., Lind, H., Skaug, V., Haugen, A. and Zienolddiny, S. (2011) A combination of functional polymorphisms in the CASP8, MMP1, IL10 and SEPS1 genes affects risk of non-small cell lung cancer. Lung Cancer 71, 123–129 https://doi.org/10.1016/j.lungcan.2010.04.016
96. Meplan, C., Rohrmann, S., Steinbrecher, A., Schomburg, L., Jansen, E., Linseisen, J. et al. (2012) Polymorphisms in thioredoxin reductase and selenoprotein K genes and selenium status modulate risk of prostate cancer. PLoS ONE 7, e48709 https://doi.org/10.1371/journal.pone.0048709
97. Lan, X., Xing, J., Gao, H., Li, S., Quan, L., Jiang, Y. et al. (2017) Decreased expression of selenoproteins as a poor prognosticator of gastric cancer in humans. Biol. Trace Elem. Res. 178, 22–28 https://doi.org/10.1007/s12011-016-0908-8
98. Li, M., Cheng, W., Nie, T., Lai, H., Hu, X., Luo, J. et al. (2017) Selenoprotein K mediates the proliferation, migration, and invasion of human choriocarcinoma cells by negatively regulating human chorionic gonadotropin expression via ERK, p38 MAPK, and Akt signaling pathway. Biol. Trace Elem. Res., 16 October https://doi.org/10.1007/s12011-017-1155-3
99. Guerriero, E., Accardo, M., Capone, F., Colonna, G., Castello, G. and Costantini, S. (2014) Assessment of the Selenoprotein M (SELM) over-expression on human hepatocellular carcinoma tissues by immunohistochemistry. Eur. J. Histochem. 58, 2433 https://doi.org/10.4081/ejh.2014.2433
100. Turanov, A.A., Shchedrina, V.A., Everley, R.A., Lobanov, A.V., Yim, S.H., Marino, S.M. et al. (2014) Selenoprotein S is involved in maintenance and transport of multiprotein complexes. Biochem. J. 462, 555–565 https://doi.org/10.1042/BJ20140076
101. 0UTR elements govern the incorporation of selenocysteine into selenoprotein S. PLoS ONE 8, e62102 https://doi.org/10.1371/journal.pone.0062102
102. Kryukov, G.V., Castellano, S., Novoselov, S.V., Lobanov, A.V., Zehtab, O., Guigo, R. et al. (2003) Characterization of mammalian selenoproteomes. Science 300, 1439–1443 https://doi.org/10.1126/science.1083516
103. Zeng, J., Du, S., Zhou, J. and Huang, K. (2008) Role of SelS in lipopolysaccharide-induced inflammatory response in hepatoma HepG2 cells. Arch. Biochem. Biophys. 478, 1–6 https://doi.org/10.1016/j.abb.2008.07.016
104. Fradejas, N., Pastor, M.D., Mora-Lee, S., Tranque, P. and Calvo, S. (2008) SEPS1 gene is activated during astrocyte ischemia and shows prominent antiapoptotic effects. J. Mol. Neurosci. 35, 259–265 https://doi.org/10.1007/s12031-008-9069-3
105. Kim, K.H., Gao, Y., Walder, K., Collier, G.R., Skelton, J. and Kissebah, A.H. (2007) SEPS1 protects RAW264.7 cells from pharmacological ER stress agent-induced apoptosis. Biochem. Biophys. Res. Commun. 354, 127–132 https://doi.org/10.1016/j.bbrc.2006.12.183
106. Du, S., Liu, H. and Huang, K. (2010) Influence of SelS gene silence on β-Mercaptoethanol-mediated endoplasmic reticulum stress and cell apoptosis in HepG2 cells. Biochim. Biophys. Acta 1800, 511–517 https://doi.org/10.1016/j.bbagen.2010.01.005
107. Gao, Y., Hannan, N.R., Wanyonyi, S., Konstantopolous, N., Pagnon, J., Feng, H.C. et al. (2006) Activation of the selenoprotein SEPS1 gene expression by pro-inflammatory cytokines in HepG2 cells. Cytokine 33, 246–251 https://doi.org/10.1016/j.cyto.2006.02.005
108. Gao, Y., Feng, H.C., Walder, K., Bolton, K., Sunderland, T., Bishara, N. et al. (2004) Regulation of the selenoprotein SelS by glucose deprivation and endoplasmic reticulum stress – SelS is a novel glucose-regulated protein. FEBS Lett. 563, 185–190 https://doi.org/10.1016/S0014-5793(04)00296-0
109. Zhao, Y., Li, H., Men, L.L., Huang, R.C., Zhou, H.C., Xing, Q. et al. (2013) Effects of selenoprotein S on oxidative injury in human endothelial cells. J. Transl. Med. 11, 287 https://doi.org/10.1186/1479-5876-11-287
110. Dandekar, A., Mendez, R. and Zhang, K. (2015) Cross talk between ER stress, oxidative stress, and inflammation in health and disease. Methods Mol. Biol. 1292, 205–214 https://doi.org/10.1007/978-1-4939-2522-3_15
111. Cao, S.S. and Kaufman, R.J. (2014) Endoplasmic reticulum stress and oxidative stress in cell fate decision and human disease. Antioxid. Redox Signal. 21, 396–413 https://doi.org/10.1089/ars.2014.5851
112. Ye, Y., Fu, F., Li, X., Yang, J. and Liu, H. (2016) Selenoprotein S is highly expressed in the blood vessels and prevents vascular smooth muscle cells from apoptosis. J. Cell. Biochem. 117, 106–117 https://doi.org/10.1002/jcb.25254
113. Banerjee, A., Banerjee, V., Czinn, S. and Blanchard, T. (2017) Increased reactive oxygen species levels cause ER stress and cytotoxicity in andrographolide treated colon cancer cells. Oncotarget 8, 26142–26153 https://doi.org/10.18632/oncotarget.15393
114. +-dependent SIRT1 deacetylase translates a metabolic switch into regulatory epigenetics in skeletal muscle stem cells. Cell Stem Cell 16, 171–183 https://doi.org/10.1016/j.stem.2014.12.004
115. Liu, J. and Rozovsky, S. (2013) Contribution of selenocysteine to the peroxidase activity of selenoprotein S. Biochemistry 52, 5514–5516 https://doi.org/10.1021/bi400741c
116. Liu, J., Li, F. and Rozovsky, S. (2013) The intrinsically disordered membrane protein selenoprotein S is a reductase in vitro. Biochemistry 52, 3051–3061 https://doi.org/10.1021/bi4001358
117. Liu, J. and Rozovsky, S. (2015) Membrane-bound selenoproteins. Antioxid. Redox Signal. 23, 795–813 https://doi.org/10.1089/ars.2015.6388
118. Christensen, L.C., Jensen, N.W., Vala, A., Kamarauskaite, J., Johansson, L., Winther, J.R. et al. (2012) The human selenoprotein VCP-interacting membrane protein (VIMP) is non-globular and harbors a reductase function in an intrinsically disordered region. J. Biol. Chem. 287, 26388–26399 https://doi.org/10.1074/jbc.M112.346775
119. Mahmood, D.F., Abderrazak, A., El Hadri, K., Simmet, T. and Rouis, M. (2013) The thioredoxin system as a therapeutic target in human health and disease. Antioxid. Redox Signal. 19, 1266–1303 https://doi.org/10.1089/ars.2012.4757
120. Sakurai, A., Yuasa, K., Shoji, Y., Himeno, S., Tsujimoto, M., Kunimoto, M. et al. (2004) Overexpression of thioredoxin reductase 1 regulates NF-κB activation. J. Cell. Physiol. 198, 22–30 https://doi.org/10.1002/jcp.10377
121. May, M.J. and Ghosh, S. (1998) Signal transduction through NF-κB. Immunol. Today 19, 80–88 https://doi.org/10.1016/S0167-5699(97)01197-3
122. Hirota, K., Murata, M., Sachi, Y., Nakamura, H., Takeuchi, J., Mori, K. et al. (1999) Distinct roles of thioredoxin in the cytoplasm and in the nucleus. A two-step mechanism of redox regulation of transcription factor NF-κB. J. Biol. Chem. 274, 27891–27897 https://doi.org/10.1074/jbc.274.39.27891
123. 1-antitrypsin deficiency. J. Biol. Chem. 284, 16891–16897 https://doi.org/10.1074/jbc.M109.006288
124. Ye, Y., Shibata, Y., Yun, C., Ron, D. and Rapoport, T.A. (2004) A membrane protein complex mediates retro-translocation from the ER lumen into the cytosol. Nature 429, 841–847 https://doi.org/10.1038/nature02656
125. Lee, J.H., Park, K.J., Jang, J.K., Jeon, Y.H., Ko, K.Y., Kwon, J.H. et al. (2015) Selenoprotein S-dependent selenoprotein K binding to p97(VCP) is essential for endoplasmic reticulum-associated degradation. J. Biol. Chem. 290, 29941–29952 https://doi.org/10.1074/jbc.M115.680215
126. Speckmann, B., Gerloff, K., Simms, L., Oancea, I., Shi, W., McGuckin, M.A. et al. (2014) Selenoprotein S is a marker but not a regulator of endoplasmic reticulum stress in intestinal epithelial cells. Free Radic. Biol. Med. 67, 265–277 https://doi.org/10.1016/j.freeradbiomed.2013.11.001
127. Su, M.S., He, L., Yao, Y.M., Yu, Y., Wu, Y. and Dong, J.H. (2010) [Altered hepatic expression of selenoprotein S1 in septic mouse induced by LPS attack]. Zhonghua Yi Xue Za Zhi 90, 1841–1844 PMID:20979832
128. He, L., Wang, B., Yao, Y., Su, M., Ma, H. and Jia, N. (2014) Protective effects of the SEPS1 gene on lipopolysaccharide-induced sepsis. Mol. Med. Rep. 9, 1869–1876 https://doi.org/10.3892/mmr.2014.1991
129. Wright, C.R., Allsopp, G.L., Addinsall, A.B., McRae, N.L., Andrikopoulos, S. and Stupka, N. (2017) A reduction in selenoprotein S amplifies the inflammatory profile of fast-twitch skeletal muscle in the mdx dystrophic mouse. Mediators Inflamm. 2017, 12 https://doi.org/10.1155/2017/7043429
130. Walder, K., Kantham, L., McMillan, J.S., Trevaskis, J., Kerr, L., De Silva, A. et al. (2002) Tanis: a link between type 2 diabetes and inflammation? Diabetes 51, 1859–1866 https://doi.org/10.2337/diabetes.51.6.1859
131. Barnett, M., Collier, G.R., Collier, F.M., Zimmet, P. and O’Dea, K. (1994) A cross-sectional and short-term longitudinal characterisation of NIDDM in Psammomys obesus. Diabetologia 37, 671–676 https://doi.org/10.1007/BF00417690
132. Karlsson, H.K., Tsuchida, H., Lake, S., Koistinen, H.A. and Krook, A. (2004) Relationship between serum amyloid A level and Tanis/SelS mRNA expression in skeletal muscle and adipose tissue from healthy and type 2 diabetic subjects. Diabetes 53, 1424–1428 https://doi.org/10.2337/diabetes.53.6.1424
133. Du, J.L., Sun, C.K., Lu, B., Men, L.L., Yao, J.J., An, L.J. et al. (2008) Association of SelS mRNA expression in omental adipose tissue with Homa-IR and serum amyloid A in patients with type 2 diabetes mellitus. Chin. Med. J. 121, 1165–1168 PMID:18710632
134. Olsson, M., Olsson, B., Jacobson, P., Thelle, D.S., Bjorkegren, J., Walley, A. et al. (2011) Expression of the selenoprotein S (SELS) gene in subcutaneous adipose tissue and SELS genotype are associated with metabolic risk factors. Metabolism 60, 114–120 https://doi.org/10.1016/j.metabol.2010.05.011
135. Yu, S.-s., Men, L.l., Wu, J.-l., Huang, L.-w., Xing, Q., Yao, J.-j. et al. (2016) The source of circulating selenoprotein S and its association with type 2 diabetes mellitus and atherosclerosis: a preliminary study. Cardiovasc. Diabetol. 15, 70 https://doi.org/10.1186/s12933-016-0388-3
136. Cox, A.J., Lehtinen, A.B., Xu, J., Langefeld, C.D., Freedman, B.I., Carr, J.J. et al. (2013) Polymorphisms in the Selenoprotein S gene and subclinical cardiovascular disease in the Diabetes Heart Study. Acta Diabetol. 50, 391–399 https://doi.org/10.1007/s00592-012-0440-z
137. Qiu, D., Xiao, Y., Bai, H.X., Tan, L. and Yang, L. (2015) Association of selenoprotein S gene polymorphism with ischemic stroke: how strong is the evidence? Blood Coagul. Fibrinolysis 26, 588–589 https://doi.org/10.1097/MBC.0000000000000263
138. Gao, Y., Xie, X., Ma, Y.T., Yang, Y.N., Li, X.M., Fu, Z.Y. et al. (2013) Genetic variation in Tanis was associated with elevating plasma triglyceride level in Chinese nondiabetic subjects. Lipids Health Dis. 12, 97 https://doi.org/10.1186/1476-511X-12-97
139. Alanne, M., Kristiansson, K., Auro, K., Silander, K., Kuulasmaa, K., Peltonen, L. et al. (2007) Variation in the selenoprotein S gene locus is associated with coronary heart disease and ischemic stroke in two independent Finnish cohorts. Hum. Genet. 122, 355–365 https://doi.org/10.1007/ s00439-007-0402-7
140. Hyrenbach, S., Pezzini, A., del Zotto, E., Giossi, A., Lichy, C., Kloss, M. et al. (2007) No association of the -105 promoter polymorphism of the selenoprotein S encoding gene SEPS1 with cerebrovascular disease. Eur. J. Neurol. 14, 1173–1175 https://doi.org/10.1111/j.1468-1331.2007.01898.x
141. Gao, Y., Pagnon, J., Feng, H.C., Konstantopolous, N., Jowett, J.B., Walder, K. et al. (2007) Secretion of the glucose-regulated selenoprotein SEPS1 from hepatoma cells. Biochem. Biophys. Res. Commun. 356, 636–641 https://doi.org/10.1016/j.bbrc.2007.03.018
142. Jayaraman, S., Haupt, C. and Gursky, O. (2016) Paradoxical effects of SAA on lipoprotein oxidation suggest a new antioxidant function for SAA. J. Lipid Res. 57, 2138–2149 https://doi.org/10.1194/jlr.M071191
143. Arbogast, S. and Ferreiro, A. (2010) Selenoproteins and protection against oxidative stress: selenoprotein N as a novel player at the crossroads of redox signaling and calcium homeostasis. Antioxid. Redox Signal. 12, 893–904 https://doi.org/10.1089/ars.2009.2890
144. Lescure, A., Rederstorff, M., Krol, A., Guicheney, P. and Allamand, V. (2009) Selenoprotein function and muscle disease. Biochim. Biophys. Acta 1790, 1569–1574 https://doi.org/10.1016/j.bbagen.2009.03.002
145. Arbogast, S., Beuvin, M., Fraysse, B., Zhou, H., Muntoni, F. and Ferreiro, A. (2009) Oxidative stress in SEPN1-related myopathy: from pathophysiology to treatment. Ann. Neurol. 65, 677–686 https://doi.org/10.1002/ana.21644
146. Marino, M., Stoilova, T., Giorgi, C., Bachi, A., Cattaneo, A., Auricchio, A. et al. (2015) SEPN1, an endoplasmic reticulum-localized selenoprotein linked to skeletal muscle pathology, counteracts hyperoxidation by means of redox-regulating SERCA2 pump activity. Hum. Mol. Genet. 24, 1843–1855 https://doi.org/10.1093/hmg/ddu602
147. Petit, N., Lescure, A., Rederstorff, M., Krol, A., Moghadaszadeh, B., Wewer, U.M. et al. (2003) Selenoprotein N: an endoplasmic reticulum glycoprotein with an early developmental expression pattern. Hum. Mol. Genet. 12, 1045–1053 https://doi.org/10.1093/hmg/ddg115
148. Stoytcheva, Z.R. and Berry, M.J. (2009) Transcriptional regulation of mammalian selenoprotein expression. Biochim. Biophys. Acta 1790, 1429–1440 https://doi.org/10.1016/j.bbagen.2009.05.012
149. Deniziak, M., Thisse, C., Rederstorff, M., Hindelang, C., Thisse, B. and Lescure, A. (2007) Loss of selenoprotein N function causes disruption of muscle architecture in the zebrafish embryo. Exp. Cell Res. 313, 156–167 https://doi.org/10.1016/j.yexcr.2006.10.005
150. Bodnar, D., Ruzsnavszky, O., Olah, T., Dienes, B., Balatoni, I., Ungvari, E. et al. (2016) Dietary selenium augments sarcoplasmic calcium release and mechanical performance in mice. Nutr. Metab. 13, 76 https://doi.org/10.1186/s12986-016-0134-6
151. Jurynec, M.J., Xia, R., Mackrill, J.J., Gunther, D., Crawford, T., Flanigan, K.M. et al. (2008) Selenoprotein N is required for ryanodine receptor calcium release channel activity in human and zebrafish muscle. Proc. Natl Acad. Sci. U.S.A. 105, 12485–12490 https://doi.org/10.1073/pnas.0806015105
152. Srikanthan, P. and Karlamangla, A.S. (2011) Relative muscle mass is inversely associated with insulin resistance and prediabetes. Findings from the third National Health and Nutrition Examination Survey. J. Clin. Endocrinol. Metab. 96, 2898–2903 https://doi.org/10.1210/jc.2011-0435
153. Meissner, G. (2002) Regulation of mammalian ryanodine receptors. Front. Biosci. 7, d2072–d2080 https://doi.org/10.2741/A899
154. Aracena-Parks, P., Goonasekera, S.A., Gilman, C.P., Dirksen, R.T., Hidalgo, C. and Hamilton, S.L. (2006) Identification of cysteines involved in S-nitrosylation, S-glutathionylation, and oxidation to disulfides in ryanodine receptor type 1. J. Biol. Chem. 281, 40354–40368 https://doi.org/10.1074/jbc.M600876200
155. Moghadaszadeh, B., Rider, B.E., Lawlor, M.W., Childers, M.K., Grange, R.W., Gupta, K. et al. (2013) Selenoprotein N deficiency in mice is associated with abnormal lung development. FASEB J. 27, 1585–1599 https://doi.org/10.1096/fj.12-212688
156. 2+-dependent redox modulation of SERCA 2b by ERp57. J. Cell Biol. 164, 35–46 https://doi.org/10.1083/jcb. 200307010
157. Viner, R.I., Williams, T.D. and Schoneich, C. (1999) Peroxynitrite modification of protein thiols: oxidation, nitrosylation, and S-glutathiolation of functionally important cysteine residue(s) in the sarcoplasmic reticulum Ca-ATPase. Biochemistry 38, 12408–12415 https://doi.org/10.1021/bi9909445
158. Hansen, H.G., Schmidt, J.D., Soltoft, C.L., Ramming, T., Geertz-Hansen, H.M., Christensen, B. et al. (2012) Hyperactivity of the Ero1α oxidase elicits endoplasmic reticulum stress but no broad antioxidant response. J. Biol. Chem. 287, 39513–39523 https://doi.org/10.1074/jbc.M112.405050
159. 2+ fluxes at the endoplasmic reticulum–mitochondria interface (MAM). Antioxid. Redox Signal. 16, 1077–1087 https://doi.org/10.1089/ars.2011.4004
160. Wu, J., Ruas, J.L., Estall, J.L., Rasbach, K.A., Choi, J.H., Ye, L. et al. (2011) The unfolded protein response mediates adaptation to exercise in skeletal muscle through a PGC-1α/ATF6α complex. Cell Metab. 13, 160–169 https://doi.org/10.1016/j.cmet.2011.01.003
161. Kim, H.J., Jamart, C., Deldicque, L., An, G.L., Lee, Y.H., Kim, C.K. et al. (2011) Endoplasmic reticulum stress markers and ubiquitin-proteasome pathway activity in response to a 200-km run. Med. Sci. Sports Exerc. 43, 18–25 https://doi.org/10.1249/MSS.0b013e3181e4c5d1
162. Terrill, J.R., Duong, M.N., Turner, R., Le Guiner, C., Boyatzis, A., Kettle, A.J. et al. (2016) Levels of inflammation and oxidative stress, and a role for taurine in dystropathology of the Golden Retriever Muscular Dystrophy dog model for Duchenne Muscular Dystrophy. Redox Biol. 9, 276–286 https://doi.org/10.1016/j.redox.2016.08.016
163. Kim, J.H., Kwak, H.B., Thompson, L.V. and Lawler, J.M. (2013) Contribution of oxidative stress to pathology in diaphragm and limb muscles with Duchenne muscular dystrophy. J. Muscle Res. Cell Motil. 34, 1–13 https://doi.org/10.1007/s10974-012-9330-9
164. Rederstorff, M., Castets, P., Arbogast, S., Laine, J., Vassilopoulos, S., Beuvin, M. et al. (2011) Increased muscle stress-sensitivity induced by selenoprotein N inactivation in mouse: a mammalian model for SEPN1-related myopathy. PLoS ONE 6, e23094 https://doi.org/10.1371/journal.pone. 0023094
165. Misu, H., Takayama, H., Saito, Y., Mita, Y., Kikuchi, A., Ishii, K.A. et al. (2017) Deficiency of the hepatokine selenoprotein P increases responsiveness to exercise in mice through upregulation of reactive oxygen species and AMP-activated protein kinase in muscle. Nat. Med. 23, 508–516 https://doi.org/10.1038/nm.4295
166. Labunskyy, V.M., Hatfield, D.L. and Gladyshev, V.N. (2007) The Sep15 protein family: roles in disulfide bond formation and quality control in the endoplasmic reticulum. IUBMB Life 59, 1–5 https://doi.org/10.1080/15216540601126694
167. Reeves, M.A., Bellinger, F.P. and Berry, M.J. (2010) The neuroprotective functions of selenoprotein M and its role in cytosolic calcium regulation. Antioxid. Redox Signal. 12, 809–818 https://doi.org/10.1089/ars.2009.2883
168. Korotkov, K.V., Novoselov, S.V., Hatfield, D.L. and Gladyshev, V.N. (2002) Mammalian selenoprotein in which selenocysteine (Sec) incorporation is supported by a new form of Sec insertion sequence element. Mol. Cell. Biol. 22, 1402–1411 https://doi.org/10.1128/MCB.22.5.1402-1411.2002
169. Polo, A., Guariniello, S., Colonna, G., Ciliberto, G. and Costantini, S. (2016) A study on the structural features of SELK, an over-expressed protein in hepatocellular carcinoma, by molecular dynamics simulations in a lipid-water system. Mol. Biosyst. 12, 3209–3222 https://doi.org/10.1039/C6MB00469E
170. Shchedrina, V.A., Everley, R.A., Zhang, Y., Gygi, S.P., Hatfield, D.L. and Gladyshev, V.N. (2011) Selenoprotein K binds multiprotein complexes and is involved in the regulation of endoplasmic reticulum homeostasis. J. Biol. Chem. 286, 42937–42948 https://doi.org/10.1074/jbc.M111.310920
171. Lu, C., Qiu, F., Zhou, H., Peng, Y., Hao, W., Xu, J. et al. (2006) Identification and characterization of selenoprotein K: an antioxidant in cardiomyocytes. FEBS Lett. 580, 5189–5197 https://doi.org/10.1016/j.febslet.2006.08.065
172. 2+ from endoplasmic reticulum by upregulating expression of inositol 1,4,5-tris-phosphate receptor. Biochemistry 76, 1030–1036 https://doi.org/10.1134/ S0006297911090070
173. Gladyshev, V.N., Jeang, K.T., Wootton, J.C. and Hatfield, D.L. (1998) A new human selenium-containing protein. Purification, characterization, and cDNA sequence. J. Biol. Chem. 273, 8910–8915 https://doi.org/10.1074/jbc.273.15.8910
174. Ferguson, A.D., Labunskyy, V.M., Fomenko, D.E., Araç, D., Chelliah, Y., Amezcua, C.A. et al. (2006) NMR structures of the selenoproteins Sep15 and SelM reveal redox activity of a new thioredoxin-like family. J. Biol Chem. 281, 3536–3543 https://doi.org/10.1074/jbc.M511386200
175. Sun, H., Deng, T. and Fu, J. (2014) Chicken 15-kDa selenoprotein plays important antioxidative function in splenocytes. Biol. Trace Elem. Res. 161, 288–296 https://doi.org/10.1007/s12011-014-0126-1
176. Liang, Y., Lin, S.L., Wang, C.W., Yao, H.D., Zhang, Z.W. and Xu, S.W. (2014) Effect of selenium on selenoprotein expression in the adipose tissue of chickens. Biol. Trace Elem. Res. 160, 41–48 https://doi.org/10.1007/s12011-014-0024-6
177. Gromer, S., Eubel, J.K., Lee, B.L. and Jacob, J. (2005) Human selenoproteins at a glance. Cell. Mol. Life Sci. 62, 2414–2437 https://doi.org/10.1007/ s00018-005-5143-y
178. Mercer, J.G., Hoggard, N., Williams, L.M., Lawrence, C.B., Hannah, L.T. and Trayhurn, P. (1996) Localization of leptin receptor mRNA and the long form splice variant (Ob-Rb) in mouse hypothalamus and adjacent brain regions by in situ hybridization. FEBS Lett. 387, 113–116 https://doi.org/10.1016/ 0014-5793(96)00473-5
179. Barrett-Connor, E., Edelstein, S.L., Corey-Bloom, J. and Wiederholt, W.C. (1996) Weight loss precedes dementia in community-dwelling older adults. J. Am. Geriatr. Soc. 44, 1147–1152 https://doi.org/10.1111/j.1532-5415.1996.tb01362.x
180. Ott, A., Stolk, R.P., van Harskamp, F., Pols, H.A., Hofman, A. and Breteler, M.M. (1999) Diabetes mellitus and the risk of dementia: the Rotterdam study. Neurology 53, 1937–1942 https://doi.org/10.1212/WNL.53.9.1937
181. Cai, H., Cong, W.N., Ji, S., Rothman, S., Maudsley, S. and Martin, B. (2012) Metabolic dysfunction in Alzheimers disease and related neurodegenerative disorders. Curr. Alzheimer Res. 9, 5–17 https://doi.org/10.2174/156720512799015064
182. Dikiy, A., Novoselov, S.V., Fomenko, D.E., Sengupta, A., Carlson, B.A., Cerny, R.L. et al. (2007) Selt, SelW, SelH, and Rdx12: genomics and molecular insights into the functions of selenoproteins of a novel thioredoxin-like family. Biochemistry 46, 6871–6882 https://doi.org/10.1021/bi602462q
183. 2+ mobilization and neuroendocrine secretion. FASEB J. 22, 1756–1768 https://doi.org/10.1096/fj.06-075820
184. Moustafa, M.E. and Antar, H.A. (2012) A bioinformatics approach to characterize mammalian selenoprotein T. Biochem. Genet. 50, 736–747 https://doi.org/10.1007/s10528-012-9516-2
185. Yada, T., Sakurada, M., Ishihara, H., Nakata, M., Shioda, S., Yaekura, K. et al. (1997) Pituitary adenylate cyclase-activating polypeptide (PACAP) is an islet substance serving as an intra-islet amplifier of glucose-induced insulin secretion in rats. J. Physiol. 505 (Pt 2), 319–328 https://doi.org/10.1111/j.1469-7793.1997.319bb.x
186. Kawai, K., Ohse, C., Watanabe, Y., Suzuki, S., Yamashita, K. and Ohashi, S. (1992) Pituitary adenylate cyclase activating polypeptide stimulates insulin release from the isolated perfused rat pancreas. Life Sci. 50, 257–261 https://doi.org/10.1016/0024-3205(92)90332-J
187. Nakata, M., Shioda, S., Oka, Y., Maruyama, I. and Yada, T. (1999) Insulinotropin PACAP potentiates insulin-stimulated glucose uptake in 3T3 L1 cells. Peptides 20, 943–948 https://doi.org/10.1016/S0196-9781(99)00085-6
188. Arsenijevic, T., Gregoire, F., Chiadak, J., Courtequisse, E., Bolaky, N., Perret, J. et al. (2013) Pituitary adenylate cyclase activating peptide (PACAP) participates in adipogenesis by activating ERK signaling pathway. PLoS ONE 8, e72607 https://doi.org/10.1371/journal.pone.0072607
189. Adams, B.A., Gray, S.L., Isaac, E.R., Bianco, A.C., Vidal-Puig, A.J. and Sherwood, N.M. (2008) Feeding and metabolism in mice lacking pituitary adenylate cyclase-activating polypeptide. Endocrinology 149, 1571–1580 https://doi.org/10.1210/en.2007-0515
190. Curcio-Morelli, C., Zavacki, A.M., Christofollete, M., Gereben, B., de Freitas, B.C., Harney, J.W. et al. (2003) Deubiquitination of type 2 iodothyronine deiodinase by von Hippel-Lindau protein-interacting deubiquitinating enzymes regulates thyroid hormone activation. J. Clin. Invest. 112, 189–196 https://doi.org/10.1172/JCI18348
191. Salvatore, D., Harney, J.W. and Larsen, P.R. (1999) Mutation of the Secys residue 266 in human type 2 selenodeiodinase alters 75Se incorporation without affecting its biochemical properties. Biochimie 81, 535–538 https://doi.org/10.1016/S0300-9084(99)80106-0
192. Salvatore, D., Simonides, W.S., Dentice, M., Zavacki, A.M. and Larsen, P.R. (2014) Thyroid hormones and skeletal muscle — new insights and potential implications. Nat. Rev. Endocrinol. 10, 206–214 https://doi.org/10.1038/nrendo.2013.238
193. Dentice, M., Marsili, A., Ambrosio, R., Guardiola, O., Sibilio, A., Paik, J.H. et al. (2010) The FoxO3/type 2 deiodinase pathway is required for normal mouse myogenesis and muscle regeneration. J. Clin. Invest. 120, 4021–4030 https://doi.org/10.1172/JCI43670
194. Accili, D. and Arden, K.C. (2004) Foxos at the crossroads of cellular metabolism, differentiation, and transformation. Cell 117, 421–426 https://doi.org/10.1016/S0092-8674(04)00452-0
195. Sanchez, A.M., Candau, R.B. and Bernardi, H. (2014) Foxo transcription factors: their roles in the maintenance of skeletal muscle homeostasis. Cell. Mol. Life Sci. 71, 1657–1671 https://doi.org/10.1007/s00018-013-1513-z
196. de Jesus, L.A., Carvalho, S.D., Ribeiro, M.O., Schneider, M., Kim, S.W., Harney, J.W. et al. (2001) The type 2 iodothyronine deiodinase is essential for adaptive thermogenesis in brown adipose tissue. J. Clin. Invest. 108, 1379–1385 https://doi.org/10.1172/JCI200113803
197. Marsili, A., Aguayo-Mazzucato, C., Chen, T., Kumar, A., Chung, M., Lunsford, E.P. et al. (2011) Mice with a targeted deletion of the type 2 deiodinase are insulin resistant and susceptible to diet induced obesity. PLoS ONE 6, e20832 https://doi.org/10.1371/journal.pone.0020832
198. Grozovsky, R., Ribich, S., Rosene, M.L., Mulcahey, M.A., Huang, S.A., Patti, M.E. et al. (2009) Type 2 deiodinase expression is induced by peroxisomal proliferator-activated receptor-γ agonists in skeletal myocytes. Endocrinology 150, 1976–1983 https://doi.org/10.1210/en.2008-0938
199. Fonseca, T.L., Werneck-De-Castro, J.P., Castillo, M., Bocco, B.M.L.C., Fernandes, G.W., McAninch, E.A. et al. (2014) Tissue-specific inactivation of type 2 deiodinase reveals multilevel control of fatty acid oxidation by thyroid hormone in the mouse. Diabetes 63, 1594–1604 https://doi.org/10.2337/ db13-1768
200. Nair, S., Muller, Y.L., Ortega, E., Kobes, S., Bogardus, C. and Baier, L.J. (2012) Association analyses of variants in the DIO2 gene with early-onset type 2 diabetes mellitus in Pima Indians. Thyroid 22, 80–87 https://doi.org/10.1089/thy.2010.0455
201. Zhang, X., Sun, J., Han, W., Jiang, Y., Peng, S., Shan, Z. et al. (2016) The type 2 deiodinase Thr92Ala polymorphism is associated with worse glycemic control in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. J. Diabetes Res. 2016, 5928726 https://doi.org/10.1155/2016/5928726
202. Böck, A. (2000) Biosynthesis of selenoproteins — an overview. Biofactors 11, 77–78 https://doi.org/10.1002/biof.5520110122
203. Cardoso, B.R., Busse, A.L., Hare, D.J., Cominetti, C., Horst, M.A., McColl, G. et al. (2016) Pro198leu polymorphism affects the selenium status and GPx activity in response to Brazil nut intake. Food Funct. 7, 825–833 https://doi.org/10.1039/C5FO01270H
204. Ravn-Haren, G., Bugel, S., Krath, B.N., Hoac, T., Stagsted, J., Jorgensen, K. et al. (2008) A short-term intervention trial with selenate, selenium-enriched yeast and selenium-enriched milk: effects on oxidative defence regulation. Br. J. Nutr. 99, 883–892 https://doi.org/10.1017/ S0007114507825153
205. Powis, G., Gasdaska, J.R., Gasdaska, P.Y., Berggren, M., Lynn Kirkpatrick, D., Engman, L. et al. (1997) Selenium and the thioredoxin redox system: effects on cell growth and death. Oncol. Res. 9, 303–312 PMID:9406236
206. Hill, K.E., Xia, Y., Åkesson, B., Boeglin, M.E. and Burk, R.F. (1996) Selenoprotein P concentration in plasma is an index of selenium status in selenium-deficient and selenium-supplemented Chinese subjects. J. Nutr. 126, 138–145 https://doi.org/10.1093/jn/126.1.138
207. Zilaee, M. and Shirali, S. (2016) Heat shock proteins and diabetes. Can. J. Diabetes 40, 594–602 https://doi.org/10.1016/j.jcjd.2016.05.016
208. Literati-Nagy, B., Kulcsar, E., Literati-Nagy, Z., Buday, B., Peterfai, E., Horvath, T. et al. (2009) Improvement of insulin sensitivity by a novel drug, BGP-15, in insulin-resistant patients: a proof of concept randomized double-blind clinical trial. Horm. Metab. Res. 41, 374–380 https://doi.org/10.1055/ s-0028-1128142